bioMérieux sa Acquires AviaraDx Inc. for $60,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3bd19d1b-f943-4afe-8bad-7931f1d58bc3&Preview=1 -
Date
9/11/2008 -
Company Name
AviaraDx Inc. -
Mailing Address
11025 Roselle Street San Diego, CA 92121 -
Company Description
AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient’s tumor. Our tests improve the classification of cancer, support physicians to provide their patients with a more specific prognosis or individual risk assessment, and will eventually provide information critical to predict treatment response to a given therapeutic regimen. -
Website
http://www.aviaradx.com -
Transaction Type
M&A -
Transaction Amount
$60,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
French in-vitro diagnostics firm bioMerieux (BIOX.PA:) said on Thursday it bought privately held AviaraDx, Inc., based in San Diego, California for $60 million.
